Jamjoom Pharma has in a very short span of time emerged, as one of the leading pharmaceutical companies in the Afrasia... for respective APIs / DSs / RMs to warrant that Jamjoom Pharma product submissions are complying with the guidelines and meeting the...
the Director of Sales in implementing group sales strategies specifically tailored to the banking, pharma, consultancy... within the banking, pharma, consultancy, and FMCG sectors. · Sales Reporting & Forecasting: Prepare regular sales reports...
ROLE PURPOSE: The Technical Transfer Manager is responsible for leading the successful transfer of pharmaceutical processes, technologies, and products from R&D or external partners to manufacturing. This role ensures seamless communicati...
the Director of Sales in implementing group sales strategies specifically tailored to the banking, pharma, consultancy... within the banking, pharma, consultancy, and FMCG sectors. · Sales Reporting & Forecasting: Prepare regular sales reports...
It's a coin-toss of an election - but that doesn't mean we won't get a decisive result, writes the BBC's North America correspondent. Continue Reading »
Former president Donald Trump’s odds improved in betting markets, which many investors have been following for any indication on the election outcome Continue Reading »
Swiggy IPO: Swiggy's initial public offering (IPO) raised around ₹5,085 crore from investors in its anchor round, according to the company's exchange filing on Tuesday. Continue Reading »
Stock market today: Domestic benchmarks Sensex and Nifty 50 will likely be volatile due to US election result-related jitters. D-Street experts suggest investors maintain a hedge deposition and keep position sizes in check. Continue Reading »
Hindustan Zinc OFS: The floor price for the OFS is fixed at ₹505 per share. At the floor price, Hindustan Zinc's stake sale would fetch over ₹5,000 crore. Continue Reading »
US 10-year bonds fell as the market volatility rose to the highest level in a year amid US election results, reported the news agency Bloomberg. Continue Reading »
Gillette India's stock rose 27% to ₹10,466 in seven days after healthy Q2 financial results. The stock has delivered a 142.5% gain in 18 months while year-to-date, Gillette India shares are up by 61.5%, marking its most significant yearly increase since 2017. Continue Reading »